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 The hypothesis for this study was:  IFN-β expression differs between 
murine fibroblasts (A2R1 and L929) of different mouse strains upon 
infection of HSV-1.  Fluorescent microscopy was used to examine 
localization of IFN-β in the different murine fibroblast and keratinocyte cell 
lines after 6 hours of infection with herpes simplex virus type-1 (HSV-1).  
Because keratinocytes cell lines HEL-30 and PAM-212  grew in clusters, 
staining patterns in individual cells could not be determined. A notable 
difference in localization of IFN-β immune staining was seen between the 
two cell lines when infected with HSV-1.  The A2R1 cell line showed 
perinuclear (PN) localization, while the L929 cell line showed nuclear 
localization suggesting a distinction in response to HSV by these fibroblast 
lines. These responses were compared with those stimulated  by an inducer 





Poly I:C-treated fibroblasts, cytoplasmic staining was observed at 6 hours 
after treatment. 
Image J Fire program provided by National Institute of Health (NIH) 
was used to determine fluorescent intensities in both the keratinocyte cell 
lines and the fibroblast cell lines.  The fluorescent intensity was significantly 
greater in the L929 fibroblast cell line when treated with poly IC than the 
untreated L929 fibroblast.  There was no difference in fluorescent 
intensities in any of the other cell lines following poly IC treatment.   
 I attempted to measure IFN-β in the culture supernatants from the 
infected cells at different time points:  0, 6, 12 and 24 hours, from all cell 
lines (A2R1, L929, Hel-30 and Pam-212) using a Mouse Interferon Beta 
ELISA kit (range 15.6 – 1000pg/ml), but none was detected, except for an 
insignificant amount in the L929 cells stimulated with Poly IC at 24 hours.  
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On initial infection, a cell responds to a virus by producing Type 1 
interferon.  There are two subtypes of type 1 interferons:  interferon alpha 
(IFN- α) and interferon beta (IFN-β).  These interferons are released from 
infected cells and protect neighboring cells from viral invasion and virus 
replication by binding to the Type 1 interferon receptors (IFNARs) located 
on the plasma membrane of neighboring cells (Perry et al, 2005). 
 The amount of interferon produced depends on the cell type and on 
the type of pathogen.  HSV-1 has been shown to inhibit type 1 interferon 
production in certain cell types Perry et al, 2005).  In this study, IFN-β 
responses produced by several murine fibroblast and keratinocyte cell lines 
were investigated.  However, with the keratinocyte cell lines, the 
localization of IFN-β could not be studied because these cell lines grow in 
clumps so accurate cell counts and fluorescent visualization were not 
possible and therefore these data sets were omitted from this analysis 
(figure 1). There was also not a difference in the mean fluorescent intensity 




                           
                                
Figure 1:  Immunostaining of IFN-β in four different cell lines untreated at 
a 6 hour time point.  Original magnification:  20X.  Notice how the 
fibroblasts morphology is well defined and separate where with the 
keratinocytes, the morphology is not well defined and clumping occurs. 
(a)  A2R1 fibroblasts; (b)  L929 fibroblast; (c)  Pam-212keratinocyte; (d)  
Hel-30 keratinocyte.  Red circles denote where clumping is seen and 
individual cells are very difficult to discern. 
 
 
A - A2R1 Untreated 
 
B - L929 Untreated 






















Figure 2.   Mean Fluorescent Intensity using image J Fire program.  Hel-30 
and Pam-212 keratinocytes untreated, Poly IC treated and virus infected.  
There is no significant difference with the virus infected cells and the poly 
IC treated cells compared to the untreated cells. 
 
Hel-30 untreated 
Hel-30 virus infected 
Hel-30 Poly IC treated 
Pam-212 untreated 
Pam-212 virus infected 














C - Hel- Untreated 
   The hypothesis for this study was:  IFN-β expression is different in 
murine fibroblasts (A2R1 and L929) derived from different mouse strains 
and different from that of keratinocyte cell lines (Hel-30 and Pam-212) 
upon infection of HSV-1.  To demonstrate potential differences, these 
murine cell lines were infected with HSV-1 and then the expression and/or  
intracellular localization of interferon-β was determined by 
immunofluorescent microscopy.  To determine if there were varying 
amounts of IFN-β in the culture supernatant fluids, ELISA was used to 











LITERATURE REVIEW (BACKGROUND) 
HSV-1 Infection 
 HSV-1 is a double stranded DNA virus that can establish both 
productive and latent infections and persists in the body for the life of the 
carrier by becoming latent in the cell bodies of nerves, where it hides from 
the immune system. Reactivated virus can be transported by the nerve 
axon to the skin where the virus replicates and causes new sores (Norkin, 
2010).  HSV-1 infects approximately 60%-80% of the world population and 
can lead to ocular herpes, which is one of the major causes of blindness in 
the Western world. (Cunningham et al, 2006).  HSV-1 promotes a strong 
cytokine response in cells that are infected with the virus, stimulates gene 
products that interfere with the signaling pathways of type 1 interferons, 
and inhibits the synthesis of type 1 interferons. Viruses have developed 
successful strategies to overcome the protective effects of interferons 






 Because the initial site of HSV-1 infection as well as the sites for 
lesion formation involves epithelia (skin and mucous membranes) 
(figures 3 & 4), it is important to understand the structure of the 
epithelial surfaces of the body.  The skin offers a barrier of protection 
against many environmental factors and from pathogens.  The 
outermost layer of the skin is the epidermis and is made up of Merkel 
cells, keratinocytes, and also contains melanocytes and Langerhans 
cells. The epidermis contains five layers:  Stratum corneum, Stratum 
lucidum, Stratum granulosum, Stratum spinosum and Stratum 
germinativum.  There are two layers below the epidermis: the dermis 
and the hypodermis (figure 5).  The dermis is made up of two regions:  
the papillary region and the reticular region.  The papillary regions 
contain loose connective tissue that resembles fingerlike projections 
which interact with the epidermis.  The reticular region is composed of 
dense connective tissue and is also the area that contains the hair roots, 
sweat glands, sebaceous glands and blood vessels (Tortora, 2006). 
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 The hypodermis is not part of the skin and its function is to connect 
the skin with the bone and muscle.  The dermis and hypodermis both 
contain fibroblasts.  Fibroblasts are found everywhere within the body 
and have long been considered to be essential structural elements of 
tissue integrity.  Tissue-specific fibroblasts play an important role as 
immunoregulatory cells that can mount and influence immune 







Figure 3.  Illustration of the top layer of the epithelium which is 
keratinized and protects against friction and invasion from pathogens. 
Adapted from McGraw Hill, 1999. 
 
Figure 4.  Illustration of the top layer of the epithelium which is the 
non-keratinized type (mucous membrane) found in the oral cavity.  

















Interferon Beta (IFN-β) 
Interferons are proteins that are made and released by cells upon 
invasion of a pathogen.  In humans, there are many different forms 
(isotypes) of type I interferon and all of them bind to the same receptor on 
the surface of the plasma membrane and are similar in structure.  The only 
one form of beta interferon in humans also binds to the same IFNAR as the 
IFN-α molecules.  In contrast to IFN-α, IFN-β of other animal species is 
inactive in human cells (Davidson College, 2000). 
 IFN-β can act in a paracrine or autocrine fashion.  The receptor that 
is found on the plasma membrane initiates the signal transduction pathway 
after binding of IFN-β (figure 6).  Once IFN-β has bound to its receptor, the 
intracellular domains of IFNAR1 and IFNAR2 chains associate with two 
Janus-family tyrosine kinases, JAK1 and Tyk2, which transphosphorylate 
each other and phosphorylate the receptors.  IFNAR1 and IFNAR2 bind to 
STAT1 and STAT2 (signal transducer and activator of transcription1).  The 
STAT proteins dimerize and move to the nucleus where they activate 
specific genes (Peng, 2007).   
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 Interferon-β is generally produced by fibroblasts and some epithelial 
cell types. (Norkin, Virology p. 85)   Interferon-β can be induced by viruses, 
double stranded RNA and micro-organisms.  It can also be induced by 
cytokines such as TNF and IL1.  (Ibelgauft, 2011)   
Mouse Interferon beta (mu IFN-β) is very rapidly internalized by 
receptor-mediated endocytosis and binds to the nuclei of mouse 
fibroblasts.  The receptors on the nucleus of the fibroblasts are not only 
present in a higher affinity than on the plasma membrane, but the 
receptors are also more dense on the nuclear membrane than on the 
plasma membrane (Kushnaryov et al, 1985 & 1986). Kushnaryov and 
collegues also showed that after binding of mu IFN-β to the receptor on the 
plasma membrane of mouse L cells, it only took 3 minutes for most of the 






Figure 6.  Illustrations of Type 1 interferon receptors (IFNAR1 and IFNAR2) 
binding to Interferon beta in the plasma membrane of a cell.  Adapted 





Mechanisms of inducing Interferon Beta 
Type 1 interferons are transcriptionally regulated and IRF3 
(interferon regulatory factor) primarily regulates production of IFN-β 
(Figure 7). (Perry et al, 2005).  IRF3 is continually expressed in all cells and is 
found in an inactivated state in the cytoplasm of unstimulated cells. (Perry 
et al, 2005). Upon stimulation, IRF3 becomes phosphorylated, dimerizes 
and translocates into the nucleus and then activates the expression of IFN-




autocrine and paracrine fashion by binding to IFNAR.  Once this occurs, the 
JAK/STAT pathway is activated and a transcription factor complex 
(ISGF3)(IFN-stimulated gene factor 3) translocates into the nucleus and 
binds to IFN-stimulated response elements (ISRE) to induce expression of a 
large group of IFN-inducible genes.  (Perry et al, 2005). 
 Protein Kinase RNA-activated (PKR) is another signaling pathway in 
which interferon is induced. PKR is activated by interferon or double 
stranded RNA which is synthesized from infection by a virus.  PKR becomes 
phosphorylated,  which then phosphorylates EIF2A.  This phosphorylated 
EIF2A then inhibits cellular mRNA translation, and then prevents viral 
protein synthesis.  Active PKR also induces NFkB by phosphorylating IkB, 
which upregulates Interferon beta.  L929 cells utilize PKR as a predominant 
antiviral, IFN-mediated pathway when infected with HSV-1. (Harle, 2002). 
Mechanisms HSV-1 has for evading Induction of Interferon Beta  
HSV-1  inhibits the production of IFN-β by the immediate early viral 
protein ICP0 and ICP34.5.  ICP0 and ICP34.5 inhibit the nuclear 
accumulation of IRF-3 and enhance the degradation of activated IRF-3 
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which interferes with the pathway of IFN-beta production.(Melroe et al,   
2004) and (Johnson et al, 2008). 
HSV-1 blocks the signaling effects of type 1 interferons by reversing 
the effects of the double-stranded RNA-activated protein kinase (PKR).  






Figure 7.  The different pathways that are involved in the activation of 





MATERIALS AND METHODS 
Cell Culture 
L929 cells from C3H  mice and A2R1 cells from Balb/C  mice are 
fibroblasts that populate the dermal layer of the skin. These cell lines were 
cultured in Dulbecco’s Modified Eagles Medium (DMEM) (Fisher Scientific, 
Pittsburgh, PA) supplemented with 10% heat-inactivated fetal calf serum, 
and 1% gentamicin solution (50mg/ml).  The cells were grown in 100mm2 
tissue culture dishes and incubated in a humidified incubator at a 
temperature of 37o C with 5% CO2. 
Virus and Cell Infection 
HSV-1 (syn-17+) (initially provided by Dr. Nancy Sawtell, Children’s 
Hospital Medical Center, Cincinnati, OH) was titrated using Vero Cells (CCL-
8, American Type Culture Collection).  When the cytopathic effect was 
evident, the cells and supernatant were harvested and stored in 200ul 
aliquots at -80 degrees C.  The number of plaque forming units (PFU) were 
calculated after performing a plaque assay on Vero cells.  All four cells lines 
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were plated either on sterile glass  coverslips placed in 24 well plates or 
directly on 24 well culture plates, depending upon the experiment.  The 
virus was dispensed at 0.1 MOI in DMEM containing 2% calf serum on the 
cell monolayer in the 24 well culture plates when they were about 80% 
confluent and then placed in an incubator at 37o C.  The virus was left on 
the cells for 2 hours and then the culture medium was removed and 
replaced with fresh culture medium.  Mock infected cells were treated the 
same way, except 2% culture medium was used.  For the immunostaining, 
each cell line was dispensed on glass coverslips that were in 24 well plates 
and infected as previously described.  The coverslips were removed at the 6 
hour time point, which has been shown to be a significant time to see IFN-β 
production and immunostaining was performed (Rosztoczy et al, 1986);  
(Fujisawa et al, 1997); (Li et al, 2011a).    
Immunostaining for IFN-β 
At the end of the 6 hour time point, the cells were rinsed once with 
room temperature (RT) phosphate buffered saline (PBS) and then the PBS 
was removed.  10% Formalin fix which is used to preserve cell morphology 
was added and incubated at room temperature (RT) for fifteen minutes.  
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The fix was removed and quenched with sodium borohydride that was 
prepared just prior to use in PBS.  The cells were incubated in this solution 
for 15 minutes at RT.  The cells were then washed 3 times with PBS.  The 
cells were then permeabilized with 0.2% Triton-X 100 in PBS for 10 minutes 
at RT and then washed again in PBS three times.  3% BSA (Bovine Serum 
Albumin) blocking solution was added to the cells and incubated at RT for 
30 minutes.  The primary mouse IFN-β polyclonal antibody was prepared in 
the blocking buffer diluted 1:100 and then it was applied to each coverslip.  
The coverslips were placed in a humidified chamber cell side down and 
allowed to incubate at 4o C overnight.  The coverslips were transferred back 
to into their dishes and washed three times with PBS.  The secondary 
fluorescent-labeled (cyanine 5) anti-mouse IgG, was prepared and applied 
to each coverslip as described above and allowed to incubate for 2 hours at 
RT in the dark.  The coverslips were placed back into their dishes and 
washed 3 times with PBS.  The coverslips were then mounted onto glass 
slides (two on each slide) using liquid mounting media Vectashield (Vector 
Labs) and then sealed with clear nail varnish.  The slides were then analyzed 
by light microscopy.  Calibration bars were added to the pictures and were 
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saved onto the picture by merging the calibration bar with the picture 
before saving them to the computer. 
ELISA 
Cells were plated onto 24 well culture dishes and infected with virus 
as described above.  Supernatant was removed from separate wells at 
specified time points of 0, 6, 12 and 24 hours post infection and placed at -
20o C until samples could be analyzed. Untreated cells were used as the 
negative control and cells treated with Poly-IC were used as the positive 
control.  All four cell lines (Hel-30, PAM-212, L929, A2R1) were used in 3 
separate experiments.  The assay quantitates mouse interferon beta in 
media using a sandwich enzyme immunoassay.  The microtiter plate is pre-
coated with IFN-β capture monoclonal antibody to which the samples and 
standards are added. The supernatant was then prepared according to the 
manufacturers specifications for the ELISA (PBL Biomedical Laboratories, 
Piscataway, NJ).  The substrate supplied with the kit was TMB which is a 
colorimetric substrate for horseradish peroxidase (HRP).  The color intensity 
is proportional to the amount of HRP activity which is correlated to the 
amount of the target protein, in this case, IFN-β. The results were obtained 
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by reading the plate on an ELISA Plate Reader at a wavelength of 450 nm. 
This ELISA kit has an assay range of 15.6 – 1000pg/ml. 
Statistical Analysis 
 Statistical Analysis was performed using Sigma Plot 12.0.  The values 
that are expressed are the Standard Error of the Mean (SEM).  The Holm-
Sidak method was used to determine the significance between the treated 





RESULTS AND DISCUSSION 
Selection of the MOI for transfection of virus in the different cell lines 
Different MOI’s were used to determine the appropriate dilution to 
use on the cell lines.  Cytopathic effects assays were used to determine the 
MOI (data not shown)  0.1 MOI was chosen because it had cytopathic 
effects on the cells.  Data from Frey et al, 2009 were also used as reference 











IFN-β localization in A2R1 fibroblast in response to HSV-1 
A minimum of 100 cells per experiment was counted, all cells per 
field were counted with a minimum of 3 fields per experiment and 
observed for cytoplasmic fluorescence, nuclear fluorescence, or perinuclear 
fluorescence.  At least three replicates of each experiment were performed. 
The untreated A2R1 cells have nuclear localization of IFN-β.  When 
infected with the virus, both perinuclear (PN) and cytoplasmic localizations 
of IFN-β in response to the virus was observed (figures 8 & 9).    These 
results suggest that HSV-1 stimulates IFN-β expression/localization.  This 
analysis supports Frey’s findings that fibroblasts were better protected 
from HSV-1 than the keratinocytes following treatment with IFN-y which 
synergizes with the innate IFN-β response.    When treated with Poly IC, 
IFN-β becomes localized primarily in the cytoplasm compared with the 
nuclear localization of the untreated cells (figure 8C & 10).  This observation 
indicates that A2R1 fibroblast cell line was capable of producing IFN-β.  
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Figure 8.  Fluorescent microscopy of A2R1 fibroblast cells presenting IFN-β 
localization.  a.  Untreated A2R1 fibroblast with nuclear localization of 
IFN-β.  b.  Virus infected A2R1 fibroblast with perinuclear localization of 
IFN-β, 6 hr PI.  c.  Poly IC treated A2R1 fibroblast with cytoplasmic 









































Figure 9.  Percent localization of fluorescence of interferon beta in the 
perinuclear region of A2R1 fibroblasts.  The untreated cells were used as a 
control.  In The virus infected cells, the localization was measured 6 hours 




































































































Figure 10.  Percent Localization of fluorescence of Interferon Beta in the 
cytoplasm of A2R1 Fibroblasts.   
The Untreated cells were used as control.  In the virus infected cells, the 
localization was measured 6 hours after infection with HSV-1.  Difference 















































































IFN-β localization in L929 fibroblasts in response to HSV-1 
 
After six hours post infection (PI) there was nuclear localization of 
IFN-β which was the same as the untreated cells which also showed nuclear 
localization of IFN-β.  However, upon stimulation with Poly IC, the L929 cells 
displayed significant levels of cytoplasmic fluorescence compared with the 
untreated cells (figure 11A, 11C & 12); like the A2R1 fibroblasts, this 























         
 
         
 
         
 
Figure 11.  Fluorescent microscopy of L929 fibroblast cells presenting IFN-
β localization.  a.  Untreated L929 fibroblast with nuclear localization of 
IFN-β.  b.  Virus infected L929 fibroblast with nuclear localization of IFN-β, 
6 hr PI.  c.  Poly IC treated L929 fibroblast with cytoplasmic localization of 
























































Figure 12.  Percent localization of fluorescence of IFN-β 6 in L929 
fibroblasts.  The Untreated cells were used as control.  In the virus 
infected cells, the localization was measured 6 hours after infection with 
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Comparison of IFN-β localization in A2R1 fibroblast with L929 fibroblast in 
response to HSV-1 
 
Following infection when infected with virus, the A2R1 showed 
perinuclear localization while the L929 had nuclear localization (figures 13 
& 14).  Since L929 cells utilize the PKR as a predominant antiviral pathway 
(Harle et al, 2002) and HSV-1 disrupts this pathway by dephosphorylating 
PKR (Harle et al, 2002), IFN-β production and secretion is inhibited in the 

















































Figure 13.  Percent localization of fluorescence of interferon beta in the 
nucleus and perinucleus (PN) of virus infected  A2R1 and L929 fibroblast 
cell lines.  The difference in % localization is a comparison between the 
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Figure 14.   Comparison of A2R1 fibroblast with perinuclear localization 
















Comparing mean fluorescence between A2R1 fibroblast the L929 
fibroblast 
 
The mean fluorescence intensity was measured using Image J Fire 
Program to quantify IFN-β expression.   At least three fields per group and a 
minimum of three experiments performed.  The same fields were assessed 
using Image J that were used in determining the localization of IFN-β.  The 
pixel intensity was measured and the mean fluorescent intensity was 
calculated using this program.   
      When the mean fluorescence was measured, there was a significant 
difference in the L929 cells treated with poly IC compared with the 
untreated L929 cells (figures 15 & 16).  However, in the A2R1 fibroblast 
cells, the mean fluorescence was about the same as the untreated A2R1 








































Figure 15.  Poly IC treated L929 has significantly more mean fluorescence 
than the L929 untreated cell.  There is no significant difference in the 
mean fluorescence of the A2R1 fibroblast cell line.  Difference from 
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Figure 16. Mean Fluorescent Intensity using image J Fire program.  L929 
and A2R1 fibroblasts untreated, Poly IC treated and virus infected.  Note 
the difference in the untreated L929 cells with the Poly IC treated L929 
cells.  There is no significant difference between the virus infected cells 
and the untreated cells.  
L929 Untreated 
L929 Poly IC treated 
L929 Virus infected 
A2R1 Untreated 
A2R1 Poly IC treated 

















I attempted to measure IFN-beta in the culture supernatants from the 
infected cells from all four cell lines at different time points:  0, 6, 12 and 24 
hours, using a Mouse Interferon Beta ELISA kit (range 15.6 – 1000pg/ml), 
but could not detect any IFN-β within this range.   A detectable, but 
insignificant amount was released by the L929 cells stimulated with Poly IC 
at 24 hours.  The control standards that were supplied with the kit gave the 




























CONCLUSION AND FUTURE STUDIES 
 
HSV-1 has evolved several successful strategies to overcome the 
antiviral state produced by the cell upon infection.  A difference in 
localization of IFN-β was noted between the A2R1 fibroblast and the L929 
fibroblast at 6 hours after infection with HSV-1.  A2R1 cells showed 
perinuclear fluorescence while the L929 fibroblasts exhibited nuclear 
localization.  HSV-1 infected L929 cells appeared unresponsive to IFN-β 
production in comparison with uninfected L929 cells which also showed 
nuclear localization.  It is difficult to interpret the nuclear staining for IFN-β 
in the infected cells.  Since the culture medium contained 10% calf serum, 
mitogens in the serum could have stimulated expression of IFN-β.  Culturing 
the fibroblast cell lines in serum-free medium would address this concern.  
Removing serum-induced mitogenicity should reduce or eliminate IFN-β 




Another aspect of the nuclear staining pattern to be investigated 
involves the observation of Kushnaryov et al. (1985 and 1986) that the 
nuclear envelope contains a denser distribution as well as higher affinity 
receptors for IFN-β than does the plasma membrane of murine fibroblasts. 
If the nuclear envelope of mitogen-stimulated fibroblasts were saturated 
with IFN-β-receptor interactions, the entire nucleus would appear 
fluorescent when the whole cell is observed microscopically. Using confocal 
microscopy to optically section the cell should differentiate between 
staining of the nuclear envelope and the nucleoplasm.  In addition, results 
of confocal co-localization experiments using different fluorescent tags for 
antibodies to nuclear pore proteins and IFN-β would indicate whether IFN-β 
was exiting the nucleus or being synthesized at the nuclear envelope.   
Upon stimulation with Poly IC, both fibroblast cell lines display 
cytoplasmic fluorescent localization, both of which are significant when 
compared to the untreated cells. Perinuclear staining for IFN-β would 
suggest successful egress or synthesis and cytoplasmic staining of IFN-β, as 
seen in the poly-IC-stimulated cells.  This would indicate successful 
synthesis of IFN-β and accumulation in the cytoplasm. 
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The use of phase-contrast microscopy in conjunction with fluorescent 
microscopy would show differences in the numbers of intact cells stained 
as opposed to unstained cells.  For example, in the Image J Fire analysis 
many fewer cells showed fluorescent staining in the virus-infected samples 
at six hours after infection, a time at which viral lysis would not have 
occurred. The use of phase-contrast microscopy would determine whether 
some of the cells had not stained positive for IFN-β. 
 Frey (2009) noted that L929 fibroblasts were better protected from 
HSV-1 than keratinocytes following treatment with IFN-  and suggested 
that the IFN- synergizes with the innate IFN-β response.    He also noted 
that IFN-β mRNA transcripts were not enhanced in HSV-1-infected L929 
cells over those seen in uninfected cells (Frey, 2009). In a future study, it 
would be of interest to determine whether IFN--treated L929 fibroblasts 
are able to produce both IFN-β transcripts (as detected by PCR) and protein 
(as detected by perinuclear and cytoplasmic localization ) as well as 
secreted IFN-β ( as detected in an ELISA assay). The synergistic or additive 
anti-viral relationship between IFN- and IFN-β in eliciting a greater IFN-β 
response in the A2R1 fibroblast can be measured in a virus plaque assay.  
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Greater cell survival and fewer virus plaques should be detected in HSV-1 
infected cells pretreated with both IFN-β and IFN- than with either IFN.  
  Examining the IFN-β response in IFN--treated keratinocyte cell lines 
would also be of interest.  Frey et al (2009) showed that keratinocytes (HEL-
30) were refractory to IFN- induction of an antiviral state upon HSV-1 
infection. In contrast, IFN- induced an antiviral state in fibroblasts (L929).  
This effect in keratinocytes was attributed to the production of suppressor 
of cytokine signaling-1 (SOCS-1) which played an important role in the 
inhibition of the antiviral effect of IFN- in HSV-1-infected keratinocytes.  
Both IFN- and HSV-1 were found to upregulate production of SOCS-1 in 
keratinocytes. By comparison, HSV-1 infection exerted minimal to no effect 
on induction of SOCS-1 protein in L929 fibroblasts  (Frey et al, 2009).  It 
would be of interest, in future experiments, to determine whether an 
inhibitor of SOCS-1 would permit the keratinocyte to display an IFN-β 
response and protect the cells from lytic HSV-1 infection similar to that 
seen by Frey et al (2009). Ahmed et al (2010)  has recently found that SOCS-
1 inhibitors enhanced the IFN-β levels of L929 fibroblasts following 
infection with vaccinia virus or encephalomyocarditis virus . Keratinocytes 
treated with an inhibitor of SOCS-1 could be protected by IFN- from HSV-1 
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lytic infection (Frey et al, 2009).  It might also be worthy to investigate the 
role of IFN-α similar to that of IFN-β in these four cell lines using 
fluorescently labeled anti-murine IFN-α antibody in immune localization 
experiments. 
 Enhancement of the detection of secreted IFN-β by ELISA could be 
improved by: (1) concentrating the tissue culture supernatant fluids before 
testing; (2) inclusion of a protease inhibitor in the collected supernatant 
fluids to prevent proteolysis of any interferon in the sample;(3) examining 
treated cells at an earlier times, e.g. 2 and 4 hours post-treatment or post-
infection; and (4) selection of less dilute monoclonal antibody pairs in the 
ELISA assays.  Ahmed et al (2010) recently noted that L929 fibroblasts 
treated with an inhibitor of SOCS-1 protein for 30 and 60 minutes exhibited 
increased basal levels of IFN-β which were below 10 pg/ml as measured by 
ELISA.  Obviously, the ELISA kit used in this study was not sensitive enough 
to detect the basal IFN-β levels seen in the immunofluorescence 
experiments. 
In the innate immune responses to HSV-1 infection, Lopez  (1975) 
assumed that difference in type I interferon responses (IFN-α/β) 
augmented by type II IFN- produced by NK cells in initial infection 
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accounted for the differences seen in  response by several mouse strains to 
intraperitoneal infection with HSV-1.  Others have not confirmed these 
observations. More recently, Halford and colleagues (2004) re-evaluated 
the natural resistance to HSV-1 by some of the same mouse strains and 
noted that the individual murine species do not appear to differ in their 
innate resistance to HSV-1 infection when considering differences in virus 
strains, transmission sites, and conditions. Consequently, little can be 
attributed to the differences seen in this study in the IFN-β response to 
HSV-1 infection by A2R1 (Balb/c) and L929 (C3H) fibroblasts.  The early 
interferon responses can only account for host resistance to virus for the 
first five to seven days of infection after which the immune response 
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